| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/04/2004 | EP1386152A2 Production of polyclonal monospecific antibodies against upar variants del4, del5 and del4+5, and the use thereof for diagnostic and therapeutical purposes |
| 02/04/2004 | EP1385995A2 An early pre-symptomatic prion diagnostic blood test for encephalopathies |
| 02/04/2004 | EP1385993A2 Method of detecting and treating tuberous sclerosis complex associated disorders |
| 02/04/2004 | EP1385989A2 Il-1 inhibition for myeloma and related disorders |
| 02/04/2004 | EP1385979A2 Method for enhancing the translation and expression of recombinant proteins |
| 02/04/2004 | EP1385977A2 Secreted proteins |
| 02/04/2004 | EP1385967A2 Non aggregating fluorescent proteins and methods for using the same |
| 02/04/2004 | EP1385959A2 Method of producing recombinant antibodies against tumours |
| 02/04/2004 | EP1385958A2 Human tachykinin-related splice variants and compositions thereof |
| 02/04/2004 | EP1385957A1 Functions for d52 and ra006 nucleic acids and polypeptides |
| 02/04/2004 | EP1385955A2 Cell adhesion proteins |
| 02/04/2004 | EP1385954A2 Proteins associated with cell growth, differentiation, and death |
| 02/04/2004 | EP1385953A2 Proteins and nucleic acids encoding same |
| 02/04/2004 | EP1385945A1 Novel mutation |
| 02/04/2004 | EP1385886A1 Method for preparing human immunoglobulin concentrates for therapeutic use |
| 02/04/2004 | EP1385884A2 Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof. |
| 02/04/2004 | EP1385883A2 Transmembrane proteins |
| 02/04/2004 | EP1385882A2 Peptides and related molecules that bind to tall-1 |
| 02/04/2004 | EP1385879A1 Reproductive cancer diagnosis and therapy |
| 02/04/2004 | EP1385876A2 Gonococcal proteins and nucleic acids |
| 02/04/2004 | EP1385868A2 Steroidal derivatives |
| 02/04/2004 | EP1385864A1 Vascular endothelial growth factor 2 |
| 02/04/2004 | EP1385862A2 Vascular endothelial growth factor 2 |
| 02/04/2004 | EP1385861A2 Compositions and methods relating to lung specific genes and proteins |
| 02/04/2004 | EP1385554A2 Immunogenic conjugates of low molecular weight hyaluronic acid with polypeptide toxins |
| 02/04/2004 | EP1385547A1 Binding member which binds to both lewis-y and lewis-b haptens, and its use for treating cancer |
| 02/04/2004 | EP1385546A1 Combination therapy using anti-egfr antibodies and anti-hormonal agents |
| 02/04/2004 | EP1385545A2 Humanized antibodies |
| 02/04/2004 | EP1385544A2 Humanized antibodies |
| 02/04/2004 | EP1385543A1 Human medical treatment by application of immunoglobulin a |
| 02/04/2004 | EP1385542A2 Treatment and prevention of ebv infection and ebv-associated disorders |
| 02/04/2004 | EP1385539A1 Cancer metastasis interfering vaccine |
| 02/04/2004 | EP1385533A1 Module of pd-1 interactions with its ligands |
| 02/04/2004 | EP1185291B1 Therapeutic agent comprising a botulinum neurotoxin |
| 02/04/2004 | EP0848755B9 Vegf-related protein |
| 02/04/2004 | EP0783326B1 Process for preparing macrocyclic chelating agents and formation of chelates and conjugates thereof |
| 02/04/2004 | EP0670848B1 High molecular weight collagen-like protein polymers |
| 02/04/2004 | EP0642507B1 Transition state analogues of cocaine, their use for producing catalytic antibodies against cocaine and use of the same in diagnosis and therapy |
| 02/04/2004 | CN1473272A Method of diagnosing transmissible spongiform encephalopathy |
| 02/04/2004 | CN1473271A Agent for detecting cancer's ability to metastasize |
| 02/04/2004 | CN1473166A Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof |
| 02/04/2004 | CN1473052A PSGL-1 regulator |
| 02/04/2004 | CN1472314A Immunity expression of AIDS virus O and its use |
| 02/04/2004 | CN1472313A Antibody against AIDS virus O and its production cell series and use |
| 02/03/2004 | US6686769 Programmable I/O element circuit for high speed logic devices |
| 02/03/2004 | US6686454 Antibodies to specific regions of cyclosporine related compounds |
| 02/03/2004 | US6686453 Antifucoidan antibody |
| 02/03/2004 | US6686451 Antibodies binding to polypeptides comprising extracellular or membrane-bound proteins; use in screening of recombinant dna libraries to identify the coding sequences for novel receptor or membrane-bound proteins |
| 02/03/2004 | US6686448 Class II cytokine receptor-7 |
| 02/03/2004 | US6686444 Osteopontin derived chemotactic peptides and methods of use |
| 02/03/2004 | US6686191 Low level of anticomplement activity; contacting with trialkylphosphate and detergent then incubating |
| 02/03/2004 | US6686179 Polypeptide for use in the treatment of thrombosis, cancer, inflammation, autoimmune, and bone disorders |
| 02/03/2004 | US6686159 Methods and compositions for modulating telomerase reverse transcriptase (TERT) expression |
| 02/03/2004 | US6686153 PRV-1 gene and the use thereof |
| 02/03/2004 | US6686151 Immunological detection of RNA:DNA hybrids on microarrays |
| 02/03/2004 | US6685943 Fibronectin binding protein compositions and methods of use |
| 02/03/2004 | US6685942 Passive immmunotherapy; fab fragment that neutralizes both antigenic subgroup a and subgroup b |
| 02/03/2004 | US6685941 Immuosuppressant |
| 02/03/2004 | US6685939 Method of preventing the onset of allergic disorders |
| 02/03/2004 | US6685930 When binding molecules reach maximum concentration in tumor a liposome conjugated with antibodies is administered to clear them from the blood; single chain vh-vl binding molecules conjugated with peptide linker, solid tissue antigen binder |
| 02/03/2004 | CA2095735C Monoclonal antibodies to hepatitis c virus and method for using same |
| 02/03/2004 | CA2025597C Vaccine against lyme disease |
| 01/29/2004 | WO2004009832A1 High throughput production of antibodies to genomic-derived proteins |
| 01/29/2004 | WO2004009805A1 Novel process for producing antibody enzyme, novel antibody enzyme and utilization thereof |
| 01/29/2004 | WO2004009789A2 Targeted adenoviral vector displaying immunoglobulin-binding domain and uses thereof |
| 01/29/2004 | WO2004009782A2 Methods for generating enhanced antibody-producing cell lines with improved growth characteristics |
| 01/29/2004 | WO2004009777A2 Compositions and methods to select dendritic cells from a heterogeneous cell population |
| 01/29/2004 | WO2004009776A2 TREATMENT OF TNFα RELATED DISORDERS |
| 01/29/2004 | WO2004009773A2 Methods and compositions for activating or inhibiting vegf-d and vegf-c |
| 01/29/2004 | WO2004009762A2 Flea and tick octopamine receptor nucleic acid molecules, proteins and thereof |
| 01/29/2004 | WO2004009759A2 Novel proteins in enteroaggregative escherichia coli (eaec) useful for diagnosis and therapy of eaec infections |
| 01/29/2004 | WO2004009758A2 Embryonic stem cell markers and uses thereof |
| 01/29/2004 | WO2004009641A1 aPC NON-NEUTRALIZING ANTIBODY |
| 01/29/2004 | WO2004009640A1 Antibody against antibacterial peptide and utilization thereof |
| 01/29/2004 | WO2004009639A1 Single chain antibody and utilization thereof |
| 01/29/2004 | WO2004009638A1 Therapeutic antibodies with reduced side effects |
| 01/29/2004 | WO2004009632A2 Method for the production of an immunostimulating mucin (muc1) |
| 01/29/2004 | WO2004009618A2 Recombinant production of mixtures of antibodies |
| 01/29/2004 | WO2004009615A2 Cd40-ligand lacking native-pattern glycosylation |
| 01/29/2004 | WO2004009133A1 Adenoviral vector incorporating zipper peptide-modified fiber protein and uses thereof |
| 01/29/2004 | WO2004009109A1 Methods for detecting deantigenized t cell epitopes and uses thereof |
| 01/29/2004 | WO2004009033A2 Methods of modulating proliferative conditions |
| 01/29/2004 | WO2004008946A2 Methods of diagnosing and treating pre-eclampsia or clamp |
| 01/29/2004 | WO2004008824A2 Genes differentially expressed in breast cancer |
| 01/29/2004 | WO2003042367A3 Antibodies that immunospecifically bind to trail receptors |
| 01/29/2004 | WO2003041650A3 Modulation of lir function to treat rheumatoid arthritis |
| 01/29/2004 | WO2003039471A3 Catalytic antibodies raised against sarin and process for the preparation thereof |
| 01/29/2004 | WO2003020111A3 Alternatively spliced circulating tissue factor |
| 01/29/2004 | WO2003015617A3 Assay method for alzheimer's disease |
| 01/29/2004 | WO2003009803A3 Method of improving cognitive function |
| 01/29/2004 | WO2003008451A3 Modification of human variable domains |
| 01/29/2004 | WO2003000199A3 Ilt3 and ilt4-related compositions and methods |
| 01/29/2004 | WO2002099060A3 Dgks as modifiers of the p53 pathway and methods of use |
| 01/29/2004 | WO2002072794A3 Immunoglobulin superfamily proteins |
| 01/29/2004 | US20040019915 Nucleic acid and corresponding protein entitled 213P1F11 useful in treatment and detection of cancer |
| 01/29/2004 | US20040019189 Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen |
| 01/29/2004 | US20040019187 Immunomodulatory human mhc class II antigens-binding polypeptides |
| 01/29/2004 | US20040018973 Diagnosis cell proliferation; binding antibody to nucleic acids |
| 01/29/2004 | US20040018972 Autoimmune diseases; antiallergens; rheumatic diseases; antiinflammatory agents |
| 01/29/2004 | US20040018626 Replacement of immunoglobulin in endogenous cells; forming embryos stem cell |